Skip to main content
logo
Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
12.56
0.00 (0.00%)
At close: Aug 14, 2026, 4:00 PM EDT
12.62
+0.06 (0.48%)
After-hours: Aug 14, 2026, 7:34 PM EDT

Benitec Biopharma Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Revenue
---0.080.070.06
Revenue
---0.080.070.06
Revenue Growth
---2.74%23.73%-42.16%
Cost of Revenue
---0.11-0.010.12
Gross Profit
--0.110.080.06-0.06
Selling, General & Admin
28.2323.436.996.386.656.51
Research & Development
18.3718.3315.6112.7711.277.02
Operating Expenses
46.641.7722.619.1617.9213.53
Operating Income
-46.6-41.77-22.49-19.08-17.85-13.6
Interest Expense
----0.03-0.03-0.01
Interest & Investment Income
5.033.290.9---
Currency Exchange Gain (Loss)
0.23-0.070.04-0.42-0.23-0.33
Other Non Operating Income (Expenses)
-0.21-0.13-0.2-0.03-0.08-
EBT Excluding Unusual Items
-41.54-38.68-21.75-19.56-18.2-13.94
Gain (Loss) on Sale of Investments
---0-0-0.010.02
Other Unusual Items
-0.76---0.04
Pretax Income
-41.54-37.92-21.75-19.56-18.21-13.88
Net Income
-41.54-37.92-21.75-19.56-18.21-13.88
Preferred Dividends & Other Adjustments
--0.62---
Net Income to Common
-41.54-37.92-22.37-19.56-18.21-13.88
Net Income Growth
------
Shares Outstanding (Basic)
443618100
Shares Outstanding (Diluted)
443618100
Shares Change
37.41%97.17%1225.17%188.30%90.24%320.63%
EPS (Basic)
-0.93-1.05-1.22-14.12-37.88-54.94
EPS (Diluted)
-0.93-1.05-1.22-14.12-37.88-54.94
EPS Growth
------
Free Cash Flow
-19.82-23.61-19.58-18.01-15.91-13.05
Free Cash Flow Per Share
-0.45-0.65-1.07-13.00-33.10-51.66
Gross Margin
---100.00%87.67%-108.47%
Operating Margin
----25441.33%-24457.53%-23044.07%
Profit Margin
----26082.67%-24942.47%-23528.81%
Free Cash Flow Margin
----24017.33%-21797.26%-22123.73%
EBITDA
-46.54-41.7-22.4-18.95-17.69-13.37
D&A For EBITDA
0.060.070.090.140.170.23
EBIT
-46.6-41.77-22.49-19.08-17.85-13.6
SEC Filings: 10-K · 10-Q